Butalbital
Back to searchMolecule Structure
Scientific Name
Butalbital
Description of the Drug
Butalbital is a barbiturate drug used for symptomatic treatment of tension-type headache in various combinations with acetaminophen, aspirin, caffeine, and codeine.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00241
http://www.drugbank.ca/drugs/DB00241
Brand Name(s)
Sandoptal
Company Owner(s)
Mirror Pharmaceuticals Llc, Dunhall Pharmaceuticals Inc, Nesher Pharmaceuticals Usa Llc, Savage Laboratories Inc Div Altana Inc, Sun Pharmaceutical Industries Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Us Chemical Marketing Group Inc, Shire Development Inc, Granules Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL79820 |
| PharmGKB | PA448695 |
| Human Metabolome Database | HMDB0014386 |
| DrugBank | DB00241 |
| PubChem: Thomson Pharma | 15018886 |
| PubChem | 2481 |
| Mcule | MCULE-4854044905 |
| LINCS | LSM-5793 |
| Nikkaji | J4.555A |
| EPA CompTox Dashboard | DTXSID6022711 |
| DrugCentral | 441 |
| Guide to Pharmacology | 7138 |
| rxnorm | BUTALBITAL |
| ChEBI | 102524 |
| ZINC | ZINC000003830347 |
